Sang Hoon Ahn Selected Research

Lamivudine (Epivir)

1/2020	Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response.
1/2017	Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adefovir combination therapy.
11/2016	Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B.
5/2016	The clinical implication of single nucleotide polymorphisms in deoxycytidine kinase in chronic hepatitis B patients treated with lamivudine.
4/2016	A 96-week randomized trial of switching to entecavir in patients who achieved virological suppression on lamivudine therapy.
1/2016	Outcome of adefovir add-on lamivudine rescue therapy of up to 5 years in patients with lamivudine-resistant chronic hepatitis B.
11/2014	Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy.
6/2014	Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B.
5/2014	Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen-positive chronic hepatitis B patients.
1/2014	Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sang Hoon Ahn Research Topics

Disease

122	Chronic Hepatitis B 02/2022 - 01/2005
111	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 03/2002
64	Fibrosis (Cirrhosis) 04/2022 - 04/2010
56	Infections 11/2021 - 06/2003
46	Neoplasms (Cancer) 01/2022 - 10/2004
38	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 02/2005
27	Hepatitis B 01/2022 - 11/2003
17	Chronic Hepatitis C 01/2021 - 12/2006
14	Liver Diseases (Liver Disease) 01/2022 - 03/2007
11	Disease Progression 04/2022 - 03/2007
11	Liver Neoplasms (Liver Cancer) 01/2022 - 03/2007
11	Thrombosis (Thrombus) 01/2020 - 03/2002
9	Hypertension (High Blood Pressure) 01/2022 - 11/2015
8	Stomach Neoplasms (Stomach Cancer) 09/2017 - 08/2012
8	Neoplasm Metastasis (Metastasis) 07/2013 - 12/2005
7	Non-alcoholic Fatty Liver Disease 01/2022 - 10/2015
7	Diabetes Mellitus 01/2022 - 08/2012
6	End Stage Liver Disease 01/2021 - 09/2009
6	Ascites 09/2019 - 09/2004
6	Virus Diseases (Viral Diseases) 11/2016 - 12/2004
5	Viremia 04/2022 - 12/2019
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 11/2010
4	Fatty Liver 10/2022 - 12/2020
4	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2017
4	Fatigue 10/2021 - 11/2018
4	Hepatitis C 01/2020 - 09/2014
4	Hepatitis 01/2019 - 07/2009
4	Liver Failure 01/2017 - 07/2009
4	Peritonitis 09/2009 - 09/2004
3	Obesity 01/2022 - 06/2021
3	Body Weight (Weight, Body) 01/2022 - 02/2015
3	Insulin Resistance 06/2021 - 01/2015
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 07/2016
3	Chronic Hepatitis (Chronic Active Hepatitis) 10/2019 - 05/2012
3	Hypoxia (Hypoxemia) 01/2016 - 01/2014
2	Pathologic Constriction (Stenosis) 10/2022 - 01/2016

Drug/Important Bio-Agent (IBA)

75	Antiviral Agents (Antivirals)IBA 04/2022 - 03/2009
39	entecavir FDA Link 01/2022 - 01/2009
34	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 06/2007
34	Hepatitis B e AntigensIBA 11/2021 - 06/2003
31	Tenofovir (Viread)FDA Link 02/2022 - 09/2014
29	Lamivudine (Epivir)FDA Link 01/2020 - 11/2003
26	Alanine Transaminase (SGPT)IBA 01/2022 - 03/2009
20	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 08/2004
15	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021 - 10/2004
14	Serum AlbuminIBA 01/2022 - 10/2004
14	BilirubinIBA 11/2021 - 10/2004
14	Sorafenib (BAY 43-9006)FDA Link 10/2021 - 09/2011
12	Pharmaceutical PreparationsIBA 11/2021 - 01/2006
12	acarboxyprothrombin (PIVKA)IBA 01/2021 - 01/2007
12	InterferonsIBA 11/2020 - 01/2011
12	adefovirIBA 01/2020 - 11/2007
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2009
11	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 04/2010
11	AlbuminsIBA 11/2021 - 08/2005
11	lipoarabinomannan (LAM)IBA 01/2020 - 11/2010
10	AntigensIBA 01/2022 - 05/2012
9	Ribavirin (Virazole)FDA LinkGeneric 11/2020 - 12/2006
9	Fetal Proteins (Fetoprotein)IBA 01/2020 - 01/2011
8	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2011
7	((1- ((2- amino- 9H- purin- 9- yl)methyl)cyclopropyl)oxy)methylphosphonic acid dipivoxylIBA 02/2022 - 06/2014
6	tenofovir alafenamideIBA 01/2022 - 01/2018
6	Prothrombin (Factor II)IBA 09/2019 - 01/2007
5	maleic acid (maleate)IBA 02/2022 - 01/2019
5	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2015
5	Telbivudine FDA Link 01/2020 - 12/2007
5	NucleosidesIBA 01/2020 - 01/2011
5	Vitamin K FDA Link 09/2019 - 01/2007
5	Interferon-alpha (Interferon Alfa)IBA 11/2016 - 12/2006
5	Tumor Biomarkers (Tumor Markers)IBA 01/2016 - 01/2007
4	Aspartic Acid (Aspartate)FDA Link 01/2022 - 01/2006
4	CholesterolIBA 11/2021 - 06/2017
4	Transaminases (Aminotransferases)IBA 04/2021 - 07/2009
4	adefovir dipivoxil (Hepsera)FDA Link 03/2013 - 01/2009
4	Fluorouracil (Carac)FDA LinkGeneric 01/2013 - 07/2007
3	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2021
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 06/2021
3	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2021 - 11/2018
3	CytokinesIBA 01/2020 - 01/2018
3	wisteria lectinIBA 01/2020 - 01/2016
3	VaccinesIBA 01/2020 - 03/2012
3	CreatinineIBA 01/2020 - 04/2016
3	Carrier Proteins (Binding Protein)IBA 01/2020 - 01/2016
3	NucleotidesIBA 01/2020 - 06/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 07/2010
3	asunaprevirIBA 05/2018 - 07/2015
3	daclatasvirIBA 05/2018 - 07/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2016 - 09/2004
3	Cisplatin (Platino)FDA LinkGeneric 04/2011 - 07/2007
2	Peptides (Polypeptides)IBA 01/2022 - 01/2019
2	FumaratesIBA 01/2022 - 01/2019

Therapy/Procedure

96	Therapeutics 04/2022 - 11/2003
14	Drug Therapy (Chemotherapy) 10/2021 - 10/2004
11	Liver Transplantation 09/2020 - 11/2003
8	Gastrectomy 09/2017 - 08/2012
6	Radiotherapy 01/2020 - 03/2002
5	Chemoradiotherapy 10/2021 - 01/2011
4	Radiofrequency Ablation 09/2020 - 01/2015
3	Hepatectomy 06/2019 - 12/2005
3	Kidney Transplantation 01/2017 - 08/2004